CRISTEL Study: Monitoring of Pregnancies in Women After Solid Organ Transplantation

Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexFemale
Age18-48
SponsorHopital Foch

About this trial

The objective of this research is to obtain standardized and independent data on the number of pregnancies occurring in France and their follow-up up to 1 year postpartum (or post-pregnancy termination). This study will then aim to describe the clinical characteristics and maternal and perinatal outcomes of pregnancies in this specific population. These data will enable the dissemination of clear and up-to-date information to the medical community, thus contributing to better patient counseling and, more broadly, to couples. They will also serve to issue recommendations to optimize the planning and follow-up of pregnancies in women with solid organ transplants. Finally, this initiative aims to promote clinical research on pregnancies.

Eligibility criteria

Qualifiers

Female patient aged 18 years or older and of childbearing age

Has received a solid organ transplant, either isolated or combined (heart, liver, lung, pancreas, kidney)

Has a positive blood beta-hCG test result > 5 IU/L ("positive")

Has signed an informed consent form

Disqualifiers

Patient deprived of liberty or under legal guardianship

Patient refuses to participate in the study

Trial design

Treatments tested in this trial

  • Blood sample

Treatment groups

2,000 Participants
are divided into 1 treatment group

Locations

This trial has no locations

Sponsors and collaborators